ARCHIVES

Chemotherapy After Surgery Extends Survival By 32%

This article is from The Cancer Letter archive.

Vol. 29 No. 1 | January 27, 2006

Download PDF Visit The Full Archive

Related Articles

Drug Company Cries Foul Over Clams Of Taxotere’s Superiority To Taxol

June 11, 1993

NCI To Place 20% Cap On Grant Renewal Increases.

May 25, 2001

FDA Considering Ways To Improve Process Of Secondary Approvals Of Cancer Drugs

November 1, 1991

FDA Offers Grants For Conferences

May 1, 1987

NIH AIDS Research: Neal Nathanson To Head Office Of AIDS Research

May 29, 1998

Letters to the Editor: Burzynski: Reviewers Sought To Discredit Antineoplaston Therapy

October 30, 1998